DocGo faces severe financial distress with substantial declines across all key metrics and new going concern warnings about its ability to continue operations.
The company has added explicit language about substantial doubt regarding its ability to continue as a going concern, representing a dramatic deterioration from prior periods. This going concern qualification, combined with new warnings about potential future operating losses and liquidity constraints, signals immediate financial distress that could threaten the company's survival.
DocGo experienced a dramatic financial contraction with revenue declining substantially and operating cash flow roughly halving to $34.5M. The balance sheet contracted severely, with stockholders' equity falling 55% to $144.0M and total assets declining by over half to $217.1M, while cash reserves dropped significantly to $51.0M. This comprehensive financial deterioration across revenue, cash generation, and balance sheet strength confirms the acute liquidity crisis referenced in the company's new risk disclosures.
Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.
Total assets contracted 52.4% — asset sales, write-downs, or balance sheet optimization underway.
Operating cash flow fell 51% — earnings quality concerns; investigate working capital changes and non-cash items.
Current assets declined 49.9% — monitor working capital adequacy and short-term liquidity.
Revenue declined 47.7% — significant demand weakness or market share loss warrants investigation.
Current liabilities reduced — improved short-term financial position and working capital health.
Cash declined 42.8% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
Liabilities reduced 35% — deleveraging improves balance sheet strength and financial flexibility.
Buyback activity reduced 21.3% — capital being redeployed elsewhere or cash conservation underway.
R&D investment increased 17% — signals commitment to future product development, though near-term margin impact.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →